Paliperidone Palmitate [paliperidon palmitát]
- Terms
-
Invega
paliperidon
Xeplion
-
3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
9-Hydroxy-risperidone
9-Hydroxyrisperidone
9-OH-risperidone
Invega
Invega Sustenna
Paliperidone
R 76477
R-76477
A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.
- DUI
- D000068882 MeSH Browser
- CUI
- M0546009
- History note
- 2016 (1993)
- Public note
- 2016; PALIPERIDONE was indexed under PYRIMIDINES and ISOXAZOLES, 1993-2015; PALIPERIDONE PALMITATE was indexed under ISOXAZOLES and PALMITATE 2010-2015.
Allowable subheadings
- AD
- administration & dosage 12
- AE
- adverse effects 4
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics 2
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 2
- PD
- pharmacology 4
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 9
- TO
- toxicity
- UR
- urine